SCNI

Scinai Immunotherapeutics Ltd. SCNI

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode SCNI ONCO SPRC AZTR INDP SLXN SLRX JSPR REVB PBM
6M -64.49 % -60.17 % -76.35 % -80.41 % -85.50 % -79.66 % -95.77 % -62.77 % -63.02 % -81.32 %
YTD -76.88 % -97.10 % -81.92 % -89.74 % -91.52 % -91.66 % -97.45 % -90.94 % -97.28 % -93.76 %
1Y -76.25 % -94.59 % -69.53 % -89.16 % -91.84 % -93.44 % -97.17 % -91.37 % -94.09 % -94.55 %
3Y -97.56 % -99.95 % -99.64 % -99.97 % -95.23 % -99.05 % -99.54 % -65.52 % -99.99 % -99.98 %
5Y -99.76 % -100.00 % -99.94 % -99.97 % -99.55 % -99.05 % -99.97 % -98.10 % -100.00 % -99.98 %
10Y -99.78 % -100.00 % -99.94 % -99.97 % -99.98 % -99.05 % -100.00 % -98.05 % -100.00 % -99.98 %
From the beginning -99.84 % -100.00 % -99.94 % -99.97 % -99.98 % -99.05 % -100.00 % -98.05 % -100.00 % -99.98 %

Dividend